Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd
sales@dingminpharma.com
86-311-67260775
Model No: 656247-18-6
Transportasi: Ocean,Air,Express
Pelabuhan: Shanghai,Hangzhou
Jenis pembayaran: L/C,T/T,D/A,Paypal
Inkoterm: FOB,CIF
Product name |
Nintedanib Ethanesulfonate Salt |
CAS NO. |
656247-18-6 |
Appearance |
white powder |
Category |
Pharmaceutical Raw Materials,Active Pharmaceutical Ingredients,Bulk Drugs,Fine Chemicals. |
Standard |
purity:>99% |
Shelf life |
2 years |
Ninteranib adalah obat pertama yang disetujui FDA untuk pengelolaan fibrosis paru idiopatik (IPF), penyakit paru-paru yang jarang namun seringkali fatal. Ninteranib diyakini untuk mengerahkan mekanisme aksinya dengan menghambat beberapa reseptor tyrosine kinase, termasuk yang telah terlibat dalam patogenesis IPF (yaitu, reseptor faktor pertumbuhan fibroblast, reseptor faktor pertumbuhan yang diturunkan, dan reseptor faktor pertumbuhan endotel vaskular). Nintedanib juga menghambat kinase tyrosine nonreseptor, meskipun kontribusi penghambatan ini dalam kemanjuran obat tidak diketahui.
Item |
Specification |
Results |
Appearance |
White Powder |
White Powder |
Assay |
99.0%--101.0%(Anhydrous substance) |
99.98% |
Purity |
≥99.0% |
99.89% |
Water |
≤1.0% |
0.1% |
Sulphated ash |
≤0.5% |
0.045% |
Related substances |
Unspecified impurities for each impurity |
Complies |
Heavy Metals |
≤10ppm |
<10ppm |
Loss On Drying |
≤2.0% |
0.19% |
Kategori Produk : Yang lain
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.
Fill in more information so that we can get in touch with you faster
Privacy statement: Your privacy is very important to Us. Our company promises not to disclose your personal information to any external company with out your explicit permission.